Skip to main content
. 2023 Jul 25;12(15):e029787. doi: 10.1161/JAHA.123.029787

Figure 3. Summary of key cardiac societal guideline recommendations for the use of vasoactive medications in cardiogenic shock.

Figure 3

ESC HF, 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 16 ; ACC/AHA HF, 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure 59 ; ESC STEMI, 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST‐Segment–Elevation 58 ; AHA CS, Contemporary Management of Cardiogenic Shock: A Scientific Statement from the American Heart Association 1 ; AHA AMI‐CS, Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement from the American Heart Association. 60 ACC indicates American College of Cardiology; AHA, American Heart Association; AMI, acute myocardial infarction; CS, cardiogenic shock; ESC, European Society of Cardiology; HF, heart failure; HFSA, Heart Failure Society of America; and STEMI, ST‐segment–elevation myocardial infarction.